Body Dysmorphic Disorder

BDD diagnosis involves comprehensive psychiatric evaluation assessing preoccupation with perceived appearance flaws that are not observable or appear slight to others, along with repetitive behaviors (mirror checking, grooming, seeking reassurance) or mental acts (comparing to others). Diagnosis requires that these concerns cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. We use standardized tools like the BDD-YBOCS to assess severity accurately.

BDD results from complex interactions between multiple factors. Genetic factors play a role—BDD is more common in first-degree relatives of people with the condition or OCD. Neurobiological factors include differences in brain areas involved in visual processing and emotional regulation. Psychological factors include perfectionism, low self-esteem, and negative body experiences. Environmental factors include childhood teasing or trauma, neglect, and cultural emphasis on appearance. BDD is not caused by vanity or superficiality.

Two treatments have strong research support for BDD. Cognitive behavioral therapy (CBT) specifically adapted for BDD helps identify and challenge distorted beliefs about appearance, while exposure and response prevention (ERP) gradually reduces avoidance and compulsive behaviors. Medication—specifically SSRIs at doses typically higher than used for depression—is also effective. Combining medication with CBT often produces the best outcomes. Importantly, cosmetic procedures rarely help and can worsen BDD symptoms.

With appropriate evidence-based treatment, many people with BDD experience significant improvement or full remission of symptoms. Research shows that both CBT and SSRIs can substantially reduce preoccupation with appearance, decrease time spent on compulsive behaviors, and improve overall quality of life. While some people may need ongoing management or maintenance treatment, lasting improvement is absolutely achievable. Early intervention and treatment that specifically addresses BDD (not just co-occurring conditions) improves outcomes significantly.

SSRIs (selective serotonin reuptake inhibitors) are the first-line medication for BDD. Fluoxetine, fluvoxamine, sertraline, and escitalopram have demonstrated effectiveness. Importantly, BDD typically requires higher SSRI doses than depression—often at or near maximum recommended doses—and may take 12-16 weeks to show full benefit. If SSRIs aren't sufficient, the tricyclic antidepressant clomipramine may help, or augmentation strategies with antipsychotics may be considered. Our medication management approach carefully monitors response and adjusts treatment for optimal results.

Yes, co-occurring conditions are extremely common with BDD—the rule rather than the exception. Major depression affects approximately 75% of people with BDD. Social anxiety disorder is very common given the social avoidance BDD causes. OCD co-occurs in about 30% of cases—BDD is now classified in the OCD-related disorders category. Eating disorders may co-occur when weight or body shape is the focus of concern. Substance use disorders can develop as people attempt to cope. Comprehensive treatment addresses BDD and all co-occurring conditions.

Seek help if you spend significant time (an hour or more daily) preoccupied with perceived flaws in your appearance that others don't notice, engage in repetitive behaviors like mirror checking, grooming rituals, or skin picking, avoid social situations, photographs, or leaving home due to appearance concerns, have sought cosmetic procedures without satisfaction, or if appearance preoccupation significantly impacts work, relationships, or quality of life. BDD is often misunderstood, but it's a real, treatable condition. Early treatment improves outcomes. Call 430-288-5800 to schedule a confidential consultation.